Get started today

Rheumatoid Arthritis and Medicinal Cannabis

Presented by Dr Philip Blair, MD

About this module:

In this presentation, medicinal cannabis expert Dr Philip Blair MD explores rheumatoid arthritis, its pathogenesis, how the endocannabinoid system is involved, and evidence that key phytocannabinoids including CBD, THCA and endocannabinoid-like substances palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) may be useful in the treatment of RA. He completes this presentation with guidance on dosing with CBD, PEA and OEA and a brief case study. 

This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Learning Outcomes

At the end of this module, learners will be able to:

  • Compare and contrast signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis.
  • Explain the aetiology and pathogenesis of RA including how the endocannabinoid system appears to be involved.
  • Explain some of the scientific evidence that suggests CB2 agonists may have a role to play in treatment of RA.
  • Discuss scientific evidence that cannabidiol (CBD), THCA, β-caryophyllene, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) may be efficacious in treatment of RA.
  • Develop a treatment protocol for the treatment of RA with cannabidiol (CBD), β-caryophyllene, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA). 

Dr Philip Blair, MD

Dr. Philip Blair, MD, (Colonel, US Army, retired) is a Family Physician and consultant in disease management in the Northwest USA. He graduated from West Point in 1972, attended the University of Miami School of Medicine, training as an Army Family Physician and serving as a combat physician in the first Gulf War. After medical assignments in three continents and 29 years in uniform, he retired from the Army and has been consulting on complex disease management since 2000.

Dr. Blair has been studying, treating, and lecturing about the human body’s natural endocannabinoid system (ECS) since 2014. His goal is to restore health and performance by enhancing the ECS using diet, exercise, appropriate medications and non-psychoactive therapies.
Created with